Pharmaceuticals, Biotechnology and Life Sciences
Data from novel proprietary neurotropic adeno-associated virus (AAV) delivery capsid, STAC-BBB, demonstrated industry-leading blood-brain barrier (BBB) penetration in non-human primates…
With over 40 years of ophthalmology industry experience, Dr. Lindstrom will lead Surface Ophthalmics into its next stage of growth…
Novel AAV capsid engineered by Sangamo showed robust penetration of blood-brain barrier (BBB) and widespread transgene expression throughout brain in…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#alzheimers—Cognito Therapeutics, a leader in technology-based therapeutic interventions for neurodegenerative diseases, announced today that data from the open-label…
SAN DIEGO–(BUSINESS WIRE)–Autobahn Therapeutics, a biotechnology company leveraging its brain-targeting chemistry platform, validated biology and biomarker-driven strategies to develop restorative…
SAN DIEGO–(BUSINESS WIRE)–Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the appointment of Daniel Schumann…
Armenia and Nepal are the first of 29 countries to receive BRUKINSA SEATTLE & BASEL, Switzerland & BEIJING & CAMBRIDGE,…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #LineageCellTherapeutics—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies…
− Pre-Specified Interim Analysis Shows Positive Safety and Efficacy Results; Mezagitamab Safe and Well Tolerated − Takeda Intends to Initiate…
Latest innovation, developed in collaboration with leading pharma companies, dramatically simplifies content creation, review, publishing and regulatory submissions CHALFONT ST…